Post Marketing Surveillance for Contac Bien Z in Japan

GlaxoSmithKline (GSK)

Status: Completed

Conditions: Allergic Rhinitis; Seasonal Allergic Rhinitis

Treatments: Other: Cetrizine hydrochloride

Study type: Observational

Funder types: Industry

Identifiers

NCT02020902

RH01905 (Other Identifier)

200638

Details and patient eligibility

About

This is a post-marketing surveillance study on a marketed cetrizine hydrochloride formulation.

Enrollment: 1,552 patients

Sex: All

Ages: 15 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male and female participants, between 15-65 years of age, who purchase the marketed cetrizine hydrochloride formulation

Exclusion criteria

• Who have ever experienced allergic symptoms by taking this medication or any component of this medication, piperazine derivative (including levocetirizine, hydroxizine)
• Those who have been under 15en diagnosed with kidney disease
• Children under 15 years of age